Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Olema Pharmaceuticals, Inc. (OLMA) had Income from Continuous Operations of $-30.39M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-30.39M |
|
-- |
|
-- |
|
$34.87M |
|
$-34.87M |
|
$4.48M |
|
$-30.39M |
|
$-30.39M |
|
$-30.39M |
|
|
Income from Continuous Operations |
$-30.39M |
$-30.39M |
|
$-30.39M |
|
$-34.87M |
|
$-34.74M |
|
85.43M |
|
85.43M |
|
$-0.36 |
|
$-0.36 |
|
| Balance Sheet Financials | |
$396.66M |
|
-- |
|
$12.98M |
|
$409.64M |
|
$26.06M |
|
-- |
|
$0.12M |
|
$26.19M |
|
$383.45M |
|
$383.45M |
|
$383.45M |
|
68.33M |
|
| Cash Flow Statement Financials | |
$-43.98M |
|
$-45.08M |
|
$0.22M |
|
$139.48M |
|
$50.64M |
|
$-88.84M |
|
$4.38M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
15.22 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-43.98M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-7.93% |
|
-7.93% |
|
-7.42% |
|
-7.93% |
|
$5.61 |
|
$-0.51 |
|
$-0.51 |
|